Sign in

CIK 0001789192

  • Non-accelerated filer
  • Smaller reporting company
  • Emerging growth company

Nexentis Technologies Inc.

Sign in to watch
Ticker
NXTS
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
NV
Entity type
Operating
EIN
264684680
Phone
+972 544561349
Business address
156 FIFTH AVENUE 10TH FLOOR, CO EARTHBOUND LLC, NEW YORK, NY, 10010-7751
Former names
N2OFF, Inc., Save Foods, Inc., Save Foods Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2024-12-23 Berenstein Israel Yakov Director Grant or award +50,000 64,500
2024-12-23 Arbib Eliahou Director Grant or award +50,000 64,500
2024-12-23 Weiss Amitay Director Grant or award +350,000 450,000
2024-12-23 Itzhaik Asaf Director Grant or award +50,000 50,000
2024-09-12 Barda Lital Chief Financial Officer Grant or award +160,000 202,857
2024-09-12 Palach David Chief Executive Officer Grant or award +320,000 420,000
2023-12-20 Weiss Amitay Director Purchase +100,000 100,000
2023-12-20 Rosenbloom Ronen Director Purchase +14,500 14,500
2023-12-20 Palach David Chief Executive Officer Grant or award +57,142 100,000
2023-12-20 Kalifi Udi Ovadia Director Purchase +14,500 18,457
2023-12-20 Berenstein Israel Yakov Director Purchase +14,500 14,500
2023-12-20 Barda Lital Chief Financial Officer Grant or award +28,571 42,857
2023-12-20 Arbib Eliahou Director Purchase +14,500 14,500
2023-03-29 Palach David Chief Executive Officer Grant or award +300,000 300,000
2023-03-29 Barda Lital Chief Financial Officer Grant or award +100,000 100,000
2022-06-16 Kalifi Udi Ovadia Director Purchase +18,422 $3.30 $61K 27,692
2022-06-15 Kalifi Udi Ovadia Director Purchase +9,270 $3.16 $29K 9,270
2020-09-24 Goldwasser Benad Director Option exercise +68,000 $0.30 $20K 400,000
2020-09-24 Goldwasser Benad Director Option exercise · Warrants (Right to Buy) −68,000 125,000
2020-09-22 Goldwasser Benad Director Option exercise +132,000 $0.30 $40K 332,000

Page 2 of 3 · 42 trades